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ABSTRACT Klebsiella pneumoniae causes a wide range of infections, from urinary
tract infections to pneumonia. The lipopolysaccharide is a virulence factor of this
pathogen, although there are gaps in our understanding of its biosynthesis. Here we
report on the characterization of K. pneumoniae lpxL, which encodes one of the en-
zymes responsible for the late secondary acylation of immature lipid A molecules.
Analysis of the available K. pneumoniae genomes revealed that this pathogen’s ge-
nome encodes two orthologues of Escherichia coli LpxL. Using genetic methods and
mass spectrometry, we demonstrate that LpxL1 catalyzes the addition of laureate
and LpxL2 catalyzes the addition of myristate. Both enzymes acylated E. coli lipid A,
whereas only LpxL2 mediated K. pneumoniae lipid A acylation. We show that LpxL1 is
negatively regulated by the two-component system PhoPQ. The lipid A produced by the
lpxL2 mutant lacked the 2-hydroxymyristate, palmitate, and 4-aminoarabinose decora-
tions found in the lipid A synthesized by the wild type. The lack of 2-hydroxymyristate
was expected since LpxO modiﬁes the myristate transferred by LpxL2 to the lipid A. The
absence of the other two decorations is most likely caused by the downregulation of
phoPQ and pmrAB expression. LpxL2-dependent lipid A acylation protects Klebsiella
from polymyxins, mediates resistance to phagocytosis, limits the activation of inﬂam-
matory responses by macrophages, and is required for pathogen survival in the wax
moth (Galleria mellonella). Our ﬁndings indicate that the LpxL2 contribution to viru-
lence is dependent on LpxO-mediated hydroxylation of the LpxL2-transferred myris-
tate. Our studies suggest that LpxL2 might be a candidate target in the develop-
ment of anti-K. pneumoniae drugs.
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Lipopolysaccharide (LPS) is the major constituent in the outer membrane of Gram-negative bacteria, and it is composed of three regions: the lipid A domain, the core
oligosaccharide, and the O-antigen polysaccharide. The canonical hexa-acylated lipid A
structure is expressed by Escherichia coli K-12 and consists of a (1=-6)-linked disaccha-
ride of glucosamine phosphorylated at the 1 and 4= positions, with positions 2, 3, 2=,
and 3= being acylated with R-3-hydroxymyristoyl groups, the so-called lipid IVA. The 2=
and 3= R-3-hydroxymyristoyl groups are further acylated with laureate (C12) and my-
ristate (C14) (Fig. 1A) (1). Five enzymes are required to assemble the (1=-6)-linked
disaccharide that is characteristic of all lipid A molecules, whereas LpxK, KdtA, LpxL
(HtrB), and LpxM (MsbB) catalyze the last four enzymatic steps required to assemble the
Kdo2–hexa-acylated lipid A (1). LpxK phosphorylates the 4= position of the disaccharide
1-phosphate to form lipid IVa; the next two Kdo residues are incorporated by the
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enzyme KdtA to generate the molecule Kdo2-lipid IVA (Fig. 1A). The last steps involve
the addition of the secondary lauroyl and myristoyl residues to the distal glucosamine
unit by LpxL and LpxM, respectively (Fig. 1A), which require the Kdo disaccharide
moiety in their substrates for activity (1). When E. coli is grown at 12°C, LpxP, the cold
temperature-speciﬁc late acyltransferase, acts in place of LpxL by adding palmitoleate
(C16:1) (1).
There is lipid A diversity among Gram-negative bacteria. This is dependent on the
type and length of fatty acids, on the presence of chemical moieties, or even on the lack
of groups, such as phosphates or fatty acids, from lipid A (1, 2). Well-characterized
modiﬁcations comprise the addition of phosphoethanolamine (3), 4-amino-4-deoxy-L-
arabinose (4), or palmitate (5) and hydroxylation by the Fe2/-ketoglutarate-
dependent dioxygenase enzyme (LpxO) (6). These modiﬁcations provide resistance to
FIG 1 Synthesis of hexa-acylated lipid A in E. coli and K. pneumoniae. (A) In E. coli, LpxL transfers a laurate
(C12) group from an acyl carrier protein (ACP) onto the R-2=-hydroxymyristate acyl chain of Kdo2-lipid IVA.
Subsequently, LpxM-dependent addition of myristate (C14) onto the R-3=-hydroxymyristate residue
results in the synthesis of hexa-acylated Kdo2-lipid A. (B) In K. pneumoniae, LpxL (which we named LpxL2
in this work) and LpxM transfer myristate onto the R-3=-hydroxymyristate residue to complete the
synthesis of hexa-acylated Kdo2-lipid A. (C) Proposed lipid A structures follow previously reported
structures for K. pneumoniae (23–27). The modiﬁcations and genes responsible for each of them are
indicated.
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stresses, such as harsh pH and antimicrobial peptides (APs) (2). APs are directed to LPS
on the bacterial surface by electrostatic interactions. Colistin (polymyxin E) and poly-
myxin B are two antimicrobials which share the interaction with the anionic LPS with
mammalian APs (7). Colistin is one of the last-line antimicrobials used to treat infections
caused by multidrug-resistant strains of Gram-negative bacteria (8). Additionally, these
lipid A changes may help pathogens to modulate the activation of host defense
mechanisms by altering the activation of the Toll-like receptor 4 (TLR4)/MD-2 receptor
complex (9).
Klebsiella pneumoniae is a capsulated Gram-negative bacterial pathogen which
causes a wide range of infections, from urinary tract infections to pneumonia, with the
latter being particularly devastating among immunocompromised patients (10, 11). Of
particular concern is the increasing isolation of multidrug-resistant strains worldwide,
hence narrowing the therapeutic options for the treatment of Klebsiella infections.
However, despite the clinical relevance, there is still scant evidence on K. pneumoniae
pathogenesis at the molecular and cellular levels.
The polysaccharide sections of K. pneumoniae LPS have been extensively studied.
The core and O-antigen polysaccharides from several Klebsiella strains were character-
ized chemically and genetically, and their contribution to virulence was assessed in an
animal model of infection (12–22). In contrast, little attention has been given to K.
pneumoniae lipid A biosynthesis. We and others have demonstrated that K. pneumoniae
lipid A is hexa-acylated, with the 2= and 3= R-3-hydroxymyristoyl groups being acylated
with C14 (Fig. 1B) (23–27). The enzymatic activity of K. pneumoniae LpxM, which
catalyzes the transfer of C14 to the 3= R-3-hydroxymyristoyl group, has been conﬁrmed
experimentally (23, 26). We have uncovered that K. pneumoniae lipid A could be
decorated with palmitate, 4-amino-4-deoxy-L-arabinose, phosphoethanolamine, and
2-hydroxymyristate (C14:OH) (Fig. 1C) (23–25). The gene encoding the acyltransferase
pagP is required for the addition of palmitate to lipid A, the pmrHFIJKLM (arnBCADTEF)
loci (here referred to as the pmrF operon) are required for the synthesis and addition
of aminoarabinose to lipid A, eptA (pmrC) is necessary for the modiﬁcation of the lipid
A with phosphoethanolamine, and lpxO is responsible for modiﬁcation of the 2=-linked
secondary acyl chain with a hydroxyl group at the 2 position (Fig. 1C) (23–25). We have
demonstrated that these lipid A decorations provide resistance to APs (23–25) and K.
pneumoniae mutants lacking them are attenuated for virulence in the mouse pneu-
monia model (23–25).
The function of the K. pneumoniae LpxL late acyltransferase has not yet been
investigated. On the basis of the structure of the lipid A produced by the lpxM mutant
(23, 26), the current widely held belief is that K. pneumoniae LpxL catalyzes the transfer
of C14 to the 2= R-3-hydroxymyristoyl group (Fig. 1B). However, the presence of
hexa-acylated K. pneumoniae lipid A species has been reported, consistent with the
presence of C12 and C14 acylating the 2= and 3= R-3-hydroxymyristoyl groups, respec-
tively (23, 26). Moreover, a recent report suggests that the K. pneumoniae genome may
encode two LpxL acyltransferases responsible for late secondary acylation of immature
lipid A molecules (28). Altogether, these observations question the previously assigned
function to the lipid A late acyltransferases, chieﬂy, LpxL. The aim of this work was to
provide mechanistic insights into the function of K. pneumoniae LpxL and to investigate
its role in K. pneumoniae virulence.
RESULTS
The K. pneumoniae genome encodes two lpxL late acyltransferases. In silico
analysis of the available K. pneumoniae genomes revealed that this pathogen encodes
two orthologues of E. coli LpxL. Analysis of the genome of wild-type virulent K.
pneumoniae strain 52.145 (referred to here as strain Kp52145) (Table 1) revealed that
LpxL1 (locus tag BN49_2155) and LpxL2 (locus tag BN49_1538) are 77 and 71% identical
to E. coli LpxL, respectively. Previously, we identiﬁed the Kp52145 orthologue of E. coli
LpxM (locus tag BN49_3476) and demonstrated that it catalyzes the transfer of C14 to
the 3= R-3-hydroxymyristoyl group (23). Each Kp52145 LpxL acyltransferase was mu-
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TABLE 1 Strains and plasmids used in this study
Bacterial strain or plasmid Genotype or comments Source or reference
Strains
Escherichia coli
C600 thi thr leuB tonA lacY supE Laboratory
collectiona
SY327 (lac pro) argE(Am) rif nalA recA56 ( pir) Laboratory collection
2163 F RP4-2-Tc::Mu d dapA::(erm-pir) [Kmr Emr] 62
BN1 W3110 ΔeptA ΔlpxT ΔpagP 57
BN1 ΔlpxL BN1 ΔlpxL::FRT; the lpxL gene was inactivated This work
BN1 ΔlpxL::Tn7-T-Km-lpxL1 BN1 ΔlpxL Kmr; Tn7-T-Km-lpxL1 was integrated into the att Tn7 site This work
MG1655 F  ilvG rfb-50 rph-1 Laboratory collection
Klebsiella pneumoniae
52.145 Clinical isolate; serotype O1:K2, sequence type 66 63
52145-ΔlpxL1 Kp52145 ΔlpxL1::FRT; the lpxL1gene was inactivated This study
52145-ΔlpxL2 Kp52145 ΔlpxL2::FRT; the lpxL2 gene was inactivated This study
52145-ΔlpxL1ΔlpxL2 Kp52145 ΔlpxL1::FRT ΔlpxL2::FRT; the lpxL1 and lpxL2 genes were inactivated This study
52145-ΔlpxL2Com2 Kp52145 ΔlpxL2::FRT Kmr; Tn7-T-Km-lpxL2 was integrated into the att Tn7 site This study
52145-ΔlpxL1ΔlpxL2Com2 Kp52145 ΔlpxL1::FRT ΔlpxL2::FRT Kmr; Tn7-T-Km-lpxL2 was integrated into the
att Tn7 site
This study
52145-ΔlpxL1ΔlpxL2Com1 Kp52145 ΔlpxL1::FRT ΔlpxL2::FRT Kmr; Tn7-T-Km-lpxL1 was integrated into the
att Tn7 site
This study
52145-ΔlpxO Kp52145 ΔlpxO::FRT; the lpxO gene was inactivated This study
52145-ΔlpxOCom Kp52145 ΔlpxO::FRT; Tn7-Cm_KpnLpxOCom was integrated into the att Tn7 site This study
52145-ΔphoQGB Kp52145 ΔphoQ::Km-GenBlock Kmr; the phoQ gene was inactivated 24
52145-ΔphoQGBCom Kp52145 ΔphoQ::Km-GenBlock Cmr, Kmr; Tn7-Cm_KpnPhoPQCom was
integrated into the att Tn7 site
23
52145-ΔlpxL1ΔphoQGB Kp52145 ΔlpxL1::FRT ΔphoQ::Km-GenBlock Kmr; the lpxL1 and phoQ genes were
inactivated
This study
52145-ΔpmrF Kp52145 ΔpmrF::FRT; the pmrF gene was inactivated 24
52145-ΔpagP Kp52145 ΔpagP; the pagP gene was inactivated 25
Plasmids
pGEM-T Easy Cloning plasmid; Ampr Promega
pGEMTFRTKm Km resistance cassette source for mutagenesis ﬂanked by BamHI-FRT sites 24
pJTOOL-1  pir-based suicide vector with NotI cloning site; derived from pDS132; Cmr 51
pSTNSK-Tp pSTNSK-Tp containing a transposase for Tn7 insertion; Kmr Tpr 54
pKD46  phage red, arabinose inducible; Ampr 56
pUC18R6kT-mini-Tn7-T-Km pUC18R6kT-mini-Tn7-T complementation vector; Ampr Kmr 53
pGP-Tn7-Cm pGP-Tn7 complementation vector; Ampr Cmr 54
pFLP2 Plasmid encoding FLP to remove cassettes between FRT sites, sacB gene; Tpr 52
pGPL01 Fireﬂy luciferase (lucFF) transcriptional fusion suicide vector that carries the R6K
origin of replication; Ampr
58
pGEMTlpxL1 pGEM-T Easy containing ΔlpxL1; Ampr This study
pGEMTlpxL2 pGEM-T Easy containing ΔlpxL2; Ampr This study
pGEMTlpxL1Km pGEM-T Easy containing ΔlpxL1::Km; Kmr Ampr This study
pGEMTlpxL2Km pGEM-T Easy containing ΔlpxL2::Km; Kmr Ampr This study
pJTOOL-1-lpxL1Km pJTOOL-1 containing ΔlpxL1::Km; Kmr Cmr This study
pJTOOL-1-lpxL2Km pJTOOL-1 containing ΔlpxL2::Km; Kmr Cmr This study
pMAKSACBΔlpxO pMAKSACB containing ΔlpxO::Km-GenBlock; Cmr Kmr 25
pMAKSACBΔphoQGB pMAKSACB containing ΔphoQ::Km-GenBlock; Cmr Kmr 24
pGEMTlpxL1Com pGEM-T Easy containing the lpxL1 gene for complementation; Ampr This study
pGEMTlpxL2Com pGEM-T Easy containing the lpxL2 gene for complementation; Ampr This study
pUC18R6kT-mini-Tn7-
T-Km-lpxL1Com
pUC18R6kT-mini-Tn7-T-Km containing the lpxL1 gene for complementation;
Ampr Kmr
This study
pUC18R6kT-mini-Tn7-
T-Km-lpxL2Com
pUC18R6kT-mini-Tn7-T-Km containing the lpxL2 gene for complementation;
Ampr Kmr
This study
pGP-Tn7-Cm_KpnLpxOCom pGP-Tn7-Cm containing the lpxO gene for complementation; Ampr Cmr 23
pGP-Tn7-Cm_KpnPhoPQCom pGP-Tn7-Cm containing the phoPQ operon for complementation; Ampr Cmr 23
pGPLKpnProlpxL1 pGPL01 containing the lpxL1 promoter region; Ampr This study
pGPLKpnProlpxL2 pGPL01 containing the lpxL2 promoter region; Ampr This study
pGPLKpnPmrH pGPL01 containing the pmrH promoter region; Ampr 24
pGPLKpnProPagP pGPL01 containing the pagP promoter region; Ampr 25
aLaboratory collection, frozen bacterial stocks kept at the Bengoechea laboratory.
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tated to determine whether it contributes to the acylation of K. pneumoniae lipid A.
Control experiments showed that the growth kinetics in both rich and minimal media
were similar between the wild type and the lpxL mutant strains (see Fig. S1 in the
supplemental material). We sought to determine whether capsule levels in the lpxL
mutants were affected. This is an important control, given the crucial role played by the
K. pneumoniae capsule to thwart host defenses (20, 29–35). The levels of surface-
attached capsule were not signiﬁcantly different between the lpxL1 and lpxL2
mutant strains and the wild type (168  5.7 g/109 CFU, 170.5  4.4 g/109 CFU,
and 176.4  7.8 g/109 CFU, respectively; P  0.05 for any comparison between the
mutants and the wild type).
Lipid A was extracted from the wild type and the lpxL mutant strains using an
ammonium hydroxide-isobutyric acid method and subjected to negative-ion matrix-
assisted laser desorption ionization (MALDI)–time of ﬂight (TOF) mass spectrometry.
The lpxL1 mutant (strain 52145-ΔlpxL1) produced a lipid A similar to that previously
reported for the wild-type strain (23, 24) (Fig. 2A and B). Lipid A molecules contained
predominantly hexa-acylated species with a mass-to-charge ratio (m/z) of m/z 1824,
corresponding to two glucosamines, two phosphates, four 3-OH-C14 groups, and two
C14 groups. Hexa-acylated species of m/z 1840 corresponded to two glucosamines, two
FIG 2 K. pneumoniae LpxL2 acylates the 2= R-3-hydroxymyristoyl group with C14. Negative-ion MALDI-
TOF mass spectrometry spectra of lipid A puriﬁed from K. pneumoniae strains 52.145 (Kp52145) (A),
52145-ΔlpxL1 (lpxL1) (B), 52145-ΔlpxL2 (lpxL2) (C), 52145-ΔlpxL1ΔlpxL2 (lpxL1-lpxL2) (D), 52145-
ΔlpxL2Com2 (lpxL2Com) (E), and 52145-ΔlpxL1ΔlpxL2Com2 (lpxL1-lpxL2Com) (F) are shown. The data
represent the mass-to-charge ratio (m/z) of each lipid A species detected and are representative of those
from three extractions.
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phosphates, four 3-OH-C14 groups, one C14 group, and one C14:OH group. Other species
detected were consistent with the addition of 4-amino-4-deoxy-L-arabinose (m/z 131)
or palmitate (m/z 239) to the hexa-acylated species (m/z 1824) to produce lipid A
species of m/z 1955 and m/z 2063, respectively.
In contrast, the lipid A produced by the lpxL2 mutant (strain 52145-ΔlpxL2) (m/z
1614) was consistent with a penta-acylated lipid A corresponding to two glucosamines,
two phosphates, four 3-OH-C14 groups, and one C14 group (Fig. 2C). The lipid A
produced by the lpxL1 lpxL2 double mutant was similar to that of the lpxL2mutant (Fig.
2D). Complementation of the lpxL2 single mutant and the lpxL1 lpxL2 double mutant
with lpxL2 restored the production of wild-type lipid A (Fig. 2E and F), hence suggesting
that LpxL2 is the acyltransferase responsible for the transfer of C14 to the acyl chain
linked at the 2= position of K. pneumoniae lipid A.
To provide additional evidence that LpxL2 acylates the 2= R-3-hydroxymyristoyl
group with C14, we determined the lipid A produced by E. coli lpxL-deﬁcient strain BN1
ΔlpxL (Table 1) harboring lpxL2 cloned into the pGEM-T Easy plasmid (pGEMTlpxL2Com)
(Table 1). The BN1 strain produced bisphosphorylated, hexa-acylated lipid A containing
C12 and C14 (Fig. S2A). In contrast, MALDI-TOF analysis of the lipid A isolated from BN1
ΔlpxL yielded an expected peak at m/z 1614 (Fig. S2B), indicating bisphosphorylated,
penta-acylated lipid A lacking C12. However, mass spectrometry analysis of the lipid A
isolated from BN1 ΔlpxL/pGEMTlpxL2Com produced a peak at m/z 1824 (Fig. S2C),
thereby demonstrating that LpxL2 catalyzes the transfer of C14 to E. coli lipid A.
Notably, no lipid A modiﬁcations were detected in the lipid A produced by the lpxL2
mutant (Fig. 2C). The lack of 2-hydroxymyristate was expected since LpxO modiﬁes the
C14 transferred by LpxL2 to the 2= R-3-hydroxymyristoyl group (23, 25). However, we did
not anticipate the lack of 4-amino-4-deoxy-L-arabinose and palmitate. To provide
mechanistic insights, we sought to determine if the expression of the pmrF operon and
pagP was downregulated in the lpxL2 mutant background. To quantitatively assess the
transcription of these loci, we used two transcriptional fusions containing a promoter-
less ﬁreﬂy luciferase gene (lucFF) under the control of the relevant locus promoter
region. Each fusion (pmrH::lucFF and pagP::lucFF; Table 1) was introduced into Kp52145,
52145-ΔlpxL2, and 52145-ΔlpxL2Com2, and then the luciferase activity was measured.
Figure 3 shows that the activities of the pmrH::lucFF and pagP::lucFF fusions were
signiﬁcantly lower in the lpxL2 mutant background than in the wild-type background.
Complementation of the lpxL2 mutant restored the activities of the transcriptional
fusions to wild-type levels (Fig. 3). The fact that the two-component systems PhoPQ
and PmrAB regulate the expression of the pmrF operon and pagP, respectively, in K.
pneumoniae (24) prompted us to evaluate whether the expression of phoPQ and pmrAB
is affected in the lpxL2 mutant. Reverse transcription (RT)-quantitative PCR (qPCR)
experiments showed that phoPQ and pmrABmRNA levels were signiﬁcantly lower in the
lpxL2 mutant than in the wild type and the levels of these two mRNAs were not
different from those found in the complemented strain (Fig. 3). Altogether, these
ﬁndings suggest that the absence of 4-amino-4-deoxy-L-arabinose and palmitate mod-
iﬁcations in the lipid A produced by the lpxL2 mutant is most likely caused by
downregulation of the expression of phoPQ and pmrAB, the positive transcriptional
regulators of the pmrF operon and pagP.
Heterologous expression of LpxL1 in E. coli revealed its C12 transferase activity.
Sequence analysis of the K. pneumoniae lpxL1 gene did not reveal any frameshift or
point mutations consistent with a deleterious effect. Therefore, we investigated the
activity of K. pneumoniae LpxL1 by determining the lipid A produced by E. coli BN1
ΔlpxL harboring lpxL1 cloned into the pGEM-T Easy plasmid (pGEMTlpxL1Com). Inter-
estingly, K. pneumoniae LpxL1 restored the production of wild-type E. coli lipid A in BN1
ΔlpxL, hence indicating that LpxL1 transfers C12 to the 2= R-3-hydroxymyristoyl group
(Fig. 4A). This was also true in the Klebsiella background because MALDI-TOF analysis of
the lipid A extracted from 52145-ΔlpxL1ΔlpxL2/pGEMTlpxL1Com yielded a peak at m/z
1797 indicating the presence of bisphosphorylated, hexa-acylated lipid A containing
C12 and C14 (Fig. 4B). Further, this lipid A species was modiﬁed with palmitate (m/z
Mills et al. Infection and Immunity
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2036) (Fig. 3B). However, single-copy chromosomal complementation of the double
mutant with Tn7-T-Km-lpxL1 did not yield the peak at m/z 1797. Control experiments
conﬁrmed that E. coli BN1 ΔlpxL was complemented when this construct was used (Fig.
4D). Collectively, these results indicate that the lack of LpxL1-dependent acylation in K.
pneumoniae lipid A cannot be attributed to a general deﬁcient function of the enzyme.
PhoPQ negatively regulated lpxL1. To explain why LpxL1-dependent lipid A was
not observed in K. pneumoniae, we speculated, among other possibilities, that lpxL1
expression could be repressed in Klebsiella. To monitor the transcription of lpxL1 and
lpxL2, two transcriptional fusions in which a promoterless lucFF gene was under the
control of the acyltransferase promoters were constructed. These fusions were intro-
duced into wild-type Klebsiella, and the amount of light was determined. The expres-
sion of lpxL1::lucFF was lower than that of lpxL2::lucFF (Fig. 5A). Likewise, when lpxL
mRNA levels were analyzed by RT-qPCR, the transcript levels of lpxL1 were lower than
those of lpxL2 (Fig. 5B). These results gave initial support to our hypothesis that the
expression of lpxL1 might be repressed in K. pneumoniae.
In silico analysis of the lpxL1 promoter region revealed the presence of a PhoP
box-like sequence (36) 120 bp upstream of the initiation codon. In contrast, no PhoP
consensus motif was found in the lpxL2 promoter region. Since PhoPQ governs K.
pneumoniae loci implicated in lipid A remodeling (24), we hypothesized that PhoPQ
represses the expression of lpxL1. Indeed, the activity of the transcriptional fusion
lpxL1::lucFF was higher in the phoQ mutant background than in the wild-type one (Fig.
5C). Complementation of the phoQ mutant restored the activity of the transcriptional
fusion to wild-type levels. Similar results were obtained when the lpxL1 mRNA levels
were analyzed (Fig. 5). Of note, neither the activity of lpxL2::lucFF nor lpxL2mRNA levels
were affected in the phoQ mutant background (Fig. S3).
These ﬁndings led us to hypothesize that LpxL1-dependent lipid A acylation should
be apparent in the phoQ mutant. Supporting this hypothesis, MALDI-TOF analysis of
lipid A puriﬁed from the phoQ mutant yielded a peak at m/z 1797 (Fig. 5E). Comple-
FIG 3 Deletion of lpxL2 reduces the transcription of phoPQ and pmrAB. (A and B) Activity of the pmrH (A)
and pagP (B) promoters in K. pneumoniae 52.145 (Kp52145), 52145-ΔlpxL2 (lpxL2), and 52145-ΔlpxL2Com2
(lpxL2Com) carrying lucFF transcriptional fusions. Values (expressed in RLU) are presented as the mean 
SD from three independent experiments measured in quintuplicate. (C and D) The transcription levels of
phoP (C) and pmrA (D) in K. pneumoniae 52.145 (Kp52145), 52145-ΔlpxL2 (lpxL2), and 52145-ΔlpxL2Com2
(lpxL2Com) were determined by RT-qPCR and are shown relative to the expression levels in wild-type
bacteria (white bars). Results represent means SDs. P values indicate the signiﬁcance of the differences
versus Kp52145 determined using one-way ANOVA with Bonferroni contrasts. **, P 0.01; ***, P 0.001;
n.s., not signiﬁcant.
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mentation of the phoQ mutant restored the production of wild-type lipid A (Fig. 5F).
The m/z 1797 species in the phoQ mutant was dependent on LpxL1 activity since the
peak was absent in the lipid A from the lpxL1 phoQ double mutant (Fig. 5G).
On the whole, these results are consistent with the notion that PhoPQ negatively
regulates LpxL1-dependent lipid A acylation.
Resistance to antimicrobial peptides and Klebsiella LpxL2 late acyltransferase.
We sought to determine whether Lpx2-dependent acylation protects K. pneumoniae
from polymyxins. The lpxL2 mutant showed increased sensitivity to both polymyxins
(Table 2). Similar ﬁndings were obtained when the susceptibility to polymyxins was
evaluated after a 1-h challenge with the peptides (3 g/ml) (Fig. 6). Complemen-
tation fully restored the resistance of the lpxL2 mutant to wild-type levels (Fig. 6),
indicating that LpxL2-dependent acylation is associated with resistance to poly-
myxins.
In K. pneumoniae, the lipid A modiﬁcations with 4-amino-4-deoxy-L-arabinose and
2-hydroxymyristate mediate resistance to polymyxins (23–25). The fact that the lipid A
of the lpxL2 mutant lacked both modiﬁcations (Fig. 3) may suggest that the LpxL2
contribution to AP resistance could be indirect. The MICs of the polymyxins for the lpxO
mutant were the same as those for the lpxL2 mutant, whereas the MICs of the
polymyxins for the pmrF mutant were not signiﬁcantly different from those for the
wild-type strain (Table 2). The lpxO mutant also showed an increased susceptibility
to the polymyxins after the 1-h challenge (Fig. 6). Complementation of the lpxO
mutant restored the MIC value to the wild-type level, suggesting that the increased
susceptibility of the lpxL2 mutant to polymyxins is associated with the lack of
2-hydroxymyristate. Control experiments conﬁrmed that the lipid A produced by
the lpxO mutant still contained the m/z 1955 and m/z 2063 species, consistent with
FIG 4 K. pneumoniae LpxL2 acylates the 2= R-3-hydroxymyristoyl group with C12. The negative-ion
MALDI-TOF mass spectrometry spectra of lipid A puriﬁed from E. coli BN1 ΔlpxL complemented with K.
pneumoniae lpxL2 (BN1 ΔlpxL/pGEMTlpxL2Com) (A), 52145-ΔlpxL1ΔlpxL2 complemented with K. pneu-
moniae lpxL1 cloned into pGEM-T Easy plasmid (ΔlpxL1ΔlpxL2/pGEMTlpxL1Com) (B), 52145-ΔlpxL1ΔlpxL2
complemented with K. pneumoniae lpxL2 cloned into the Tn7 transposon (ΔlpxL1ΔlpxL2::Tn7lpxL1) (C), E.
coli BN1 ΔlpxL complemented with K. pneumoniae lpxL1 cloned into the Tn7 transposon (BN1 ΔlpxL::
Tn7lpxL1) (D) are shown. Data represent the m/z of each lipid A species detected and are representative
of those from three extractions.
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the addition of 4-amino-4-deoxy-L-arabinose and palmitate to the hexa-acylated
species (m/z 1824), respectively (Fig. S4). The growth kinetics in both rich and
minimal media were similar among the wild-type, the lpxO mutant, and the lpxL
mutant strains (Fig. S1).
FIG 5 PhoPQ negatively regulates K. pneumoniae lpxL1. (A) Activity of the lpxL1 and lpxL2 promoters in
K. pneumoniae 52.145 (Kp52145) carrying lucFF transcriptional fusions. Values (expressed in RLU) are
presented as the means  SDs from three independent experiments measured in quintuplicate. (B) The
transcription levels of lpxL1 and lpxL2 in K. pneumoniae Kp52145 were determined by RT-qPCR and are
shown relative to the expression levels in wild-type bacteria. The results represent means  SDs. (C)
Activity of the lpxL1 promoter in K. pneumoniae Kp52145, 52145-ΔphoQGB (phoQ), and 52145-
ΔphoQGBCom (phoQCom) carrying lucFF transcriptional fusions. Values (expressed in RLU) are presented
as the means  SDs from three independent experiments measured in quintuplicate. (D) The transcrip-
tion levels of lpxL1 in K. pneumoniae Kp52145, 52145-ΔphoQGB (phoQ), and 52145-ΔphoQGBCom
(phoQCom) were determined by RT-qPCR and are shown relative to the expression levels in wild-type
bacteria. Results represent means  SDs. (E to G) Negative-ion MALDI-TOF mass spectrometry spectra of
lipid A puriﬁed from 52145-ΔphoQGB (phoQ) (E), 52145-ΔphoQGBCom (phoQCom) (F), and 52145-
ΔlpxL1ΔphoQGB (lpxL1-phoQ) (G). Data represent the m/z of each lipid A species detected and are
representative of those from three extractions. P values indicate the signiﬁcance of the differences versus
Kp52145 or between the indicated comparisons determined using one-way ANOVA with Bonferroni
contrasts. *, P  0.05; **, P  0.01; ***, P  0.001; n.s., not signiﬁcant.
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Phagocytosis of K. pneumoniae lpxL2 mutant. Phagocyte-mediated killing of the
lpxL2 mutant was analyzed using a whole-blood phagocytosis assay which measures
bacterial viability following exposure to whole human blood (Fig. 7). The assay showed
that the lpxL2 mutant was recovered in signiﬁcantly lower numbers than the wild type.
Interestingly, the survival of the lpxOmutant was not signiﬁcantly different from that of
the lpxL2mutant (P 0.05) (Fig. 6), whereas the viability of the pmrF and pagPmutants
did not differ from that of the wild-type strain (Fig. S5). Complementation of the lpxO
mutant restored the level of survival to wild-type levels, indicating that the decreased
survival of the lpxL2 mutant is associated with the lack of 2-hydroxymyristate in lipid A
(Fig. 7).
Inﬂammation induced by the K. pneumoniae lpxL2 mutant. Lipid A is bound by
the TLR4/MD-2 complex, hence leading to the activation of MyD88 and TIR-domain-
containing adapter-inducing beta interferon (TRIF)-dependent innate signaling path-
ways, resulting in inﬂammation and clearance of the infection. Not surprisingly, TLR4-
governed responses are essential to clear K. pneumoniae infections (37, 38). We sought
to determine the responses induced by the lpxL2 mutant in macrophages. Figure 8
shows that the lpxL2 mutant induced higher levels of the MyD88-dependent cytokines
tumor necrosis factor alpha (TNF-) and interleukin-6 (IL-6) and the TRIF-dependent
cytokines RANTES and monocyte chemotactic protein 1 (MCP-1) in the supernatants of
bone marrow-derived macrophages than those triggered by the wild type. The strain
complemented with lpxL2 induced levels of cytokines similar to those induced by the
wild-type strain (Fig. 8). The lpxO mutant also induced higher levels of cytokines than
TABLE 2MICs of polymyxin B and colistin for K. pneumoniae strains
Strain
MICa (g/ml)
Polymyxin B Colistin
Kp52145 0.5 0.25
52145-ΔlpxL1 0.5 0.25
52145-ΔlpxL2 0.125b 0.094b
52145-ΔlpxL1ΔlpxL2 0.125b 0.094b
52145-ΔlpxL2Com2 0.5 0.25
52145-ΔlpxL1ΔlpxL2Com2 0.5 0.25
52145-ΔlpxO 0.125b 0.094b
52145-ΔlpxOCom 0.5 0.25
52145-ΔpmrF NT 0.25
52145-ΔpagP NT 0.25
aExperiments were repeated two independent times. NT, not tested.
bThe MIC was signiﬁcantly different (P  0.05, one-tailed t test) from the MIC for the wild-type strain.
FIG 6 Deletion of lpxL2 decreases K. pneumoniae resistance to polymyxins. The percent survival of K.
pneumoniae 52.145 (Kp52145), 52145-ΔlpxL2 (lpxL2), 52145-ΔlpxL2Com2 (lpxL2Com), 52145-ΔlpxO (lpxO),
and 52145-ΔlpxOCom (lpxOCom) following 1 h of exposure to polymyxin B (A) and colistin (B) is shown.
Values are presented as the means  SD from three independent experiments measured in duplicate.
P values indicate the signiﬁcance of the differences versus Kp52145 determined using one-way ANOVA
with Bonferroni contrasts. **, P  0.01; n.s., not signiﬁcant.
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the wild type, and the levels were not signiﬁcantly different from those induced by the
lpxL2mutant (P 0.05) (Fig. 8). Complementation of the lpxOmutant restored the level
of cytokine production to wild-type levels in infected macrophages (Fig. 8), suggesting
that the increased inﬂammatory response triggered by the lpxL2 mutant is due to the
lack of 2-hydroxymyristate in the lipid A.
Virulence of K. pneumoniae lpxL mutants in the Galleria mellonella model. The
wax moth (G. mellonella) infection model has recently been established to model the
FIG 7 Deletion of lpxL2 increases human phagocyte-mediated killing of K. pneumoniae. Three hundred
microliters of fresh human blood (from three different donors) was mixed with 1  107 CFU of K.
pneumoniae 52.145 (Kp52145), 52145-ΔlpxL2 (lpxL2), 52145-ΔlpxL2Com2 (lpxL2Com), 52145-ΔlpxO (lpxO),
and 52145-ΔlpxOCom (lpxOCom) and incubated at 37°C for 3 h. The bacterial counts recovered were then
divided by the initial counts. Experiments were performed with duplicate samples on three independent
occasions. P values indicate the signiﬁcance of the differences versus Kp52145 determined using
one-way ANOVA with Bonferroni contrasts. **, P  0.01; n.s., not signiﬁcant.
FIG 8 lpxL2 deletion results in the upregulation of inﬂammatory responses in macrophages upon
infection. The levels of TNF- (A), IL-6 (B), RANTES (C), and MCP-1 (D) secretion by iBMDM macrophages
stimulated for 6 h with UV-killed K. pneumoniae 52.145 (Kp52145), 52145-ΔlpxL2 (lpxL2), 52145-
ΔlpxL2Com2 (lpxL2Com), 52145-ΔlpxO (lpxO), and 52145-ΔlpxOCom (lpxOCom) are shown. P values
indicate the signiﬁcance of the differences versus Kp52145 determined using one-way ANOVA with
Bonferroni contrasts. *, P  0.05; **, P  0.01; n.s., not signiﬁcant. CON, uninfected cells.
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virulence of K. pneumoniae (30). Importantly, a strong correlation between virulence in
Galleria wax moths and that in mice (pneumonia model) has been demonstrated (30).
To determine the virulence of the lpxLmutants, we injected equivalent numbers of CFU
from the wild-type, mutant, and complemented strains into G. mellonella wax moths
and monitored bacterial killing over time. No mortality was observed in Galleria moths
into which phosphate-buffered saline (PBS) was injected (Fig. 9). After 72 h, only 20%
of the larvae injected with the wild type and the lpxL1mutant survived. In contrast, 40%
of the larvae injected with the lpxL2 and the lpxL1 lpxL2 mutants survived (P  0.05 for
any comparison versus wild-type survival). Complementation of these strains with lpxL2
restored the virulence to wild-type levels, indicating that LpxL2-dependent acylation is
important for K. pneumoniae survival and virulence in invertebrates. Interestingly, the
killing induced by the lpxO mutant was similar to that triggered by the lpxL2 mutant
(P  0.05), suggesting that the reduced virulence of the lpxL2 mutants is due to the
absence of 2-hydroxymyristate in the lipid A. Control experiments showed that the
pmrF and pagP mutants were as virulent as the wild-type strain (Fig. S6).
DISCUSSION
The work described in this study demonstrates that the K. pneumoniae genome
encodes two LpxL late acyltransferases; LpxL1 catalyzes the addition of laureate (C12),
and LpxL2 catalyzes the addition of myristate (C14). Our data establish that both
enzymes catalyze the transfer of these fatty acids to the lipid A in the E. coli back-
ground, whereas only LpxL2 mediates K. pneumoniae lipid A acylation when Klebsiella
is grown in standard laboratory medium. This study demonstrates that LpxL2 plays an
important role in K. pneumoniae infection biology since LpxL2-dependent lipid A
acylation protects the pathogen from APs, mediates resistance to phagocytosis, and
limits the activation of inﬂammatory responses by macrophages. Our results also show
that deletion of lpxL2 attenuates K. pneumoniae virulence in the G. mellonella infection
model. The fact that there is a strong correlation between the virulence of K. pneu-
moniae in the G. mellonellawax moth and mammalian models of infection (30) suggests
that LpxL2-mediated lipid A acylation is important for K. pneumoniae virulence beyond
invertebrates.
The synthesis of hexa-acylated lipid A occurs via a nine-step enzymatic pathway,
which is generally well conserved throughout all Gram-negative bacteria (1). In Enter-
obacteriaceae, the last steps of lipid A biosynthesis are dependent on LpxL and LpxM
late acyltransferases, which utilize acyl carrier proteins (ACPs) exclusively as donors (1).
lpxL and lpxM display signiﬁcant sequence similarity among Enterobacteriaceae, al-
though they may catalyze the transfer of a different fatty acid. In this context, it was
unexpected to note that the K. pneumoniae chromosome encodes two orthologues of
E. coli LpxL. Our genetic and biochemical analysis conclusively assigned the functions
of LpxL1 and LpxL2 to be laureate and myristate acyltransferases, respectively. Initially,
FIG 9 The K. pneumoniae lpxL2 mutant displays decreased virulence in the G. mellonella wax worm
infection model. The percent survival of G. mellonella over 72 h postinfection with 105 organisms of K.
pneumoniae 52.145 (Kp52145), 52145-ΔlpxL1 (lpxL1), 52145-ΔlpxL2 (lpxL2), 52145-ΔlpxL1ΔlpxL2 (lpxL1-
lpxL2), 52145-ΔlpxO (lpxO), 52145-ΔlpxL1ΔlpxL2Com2 (lpxL1-lpxL2Com2), 52145-ΔlpxOCom (lpxOCom),
and 52145-ΔlpxL2Com2 (lpxL2Com2) is shown. Thirty larvae were infected in each group. The level of
signiﬁcance was determined using the log-rank (Mantel-Cox) test with the Bonferroni correction for
multiple comparisons.
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we were puzzled by the lack of LpxL1-mediated lipid A acylation in the K. pneumoniae
background. However, the fact that we observed LpxL1-dependent lipid A species m/z
1797 in the lpxL1 lpxL2 double mutant only when lpxL1was carried by a high-copy-number
plasmid led us to hypothesize that lpxL1 expression is repressed in K. pneumoniae. Indeed,
we uncovered that LpxL1 is negatively regulated by the two-component system
PhoPQ. Interestingly, we have recently demonstrated that this is also true in K.
pneumoniae isolates with colistin resistance arising from mutational inactivation of the
mgrB regulatory gene (25). MgrB is a negative feedback regulator of PhoPQ (25, 39);
therefore, the mgrB mutation is associated with the upregulation of phoPQ, resulting in
increased expression of lpxO, pagP, pmrC, and the pmrF operon, which in turn facilitates
lipid A modiﬁcations with 2-hydroxymyristate, 4-amino-4-deoxy-L-arabinose, phos-
phoethanolamine, and palmitate (25). As anticipated, these modiﬁcations were absent
in the lipid A produced by the mgrB phoPQ double mutant, but, in perfect agreement
with the ﬁndings reported in this work, we detected the LpxL1-dependent species m/z
1797 in the lipid A produced by this mutant (25).
Our ﬁndings are reminiscent of those reported for Shigella ﬂexneri and E. coli
O157:H7 strains whose genomes encode two copies of lpxM (40–42). However, in stark
contrast to the ﬁndings for Klebsiella, in both of these pathogens one of the two LpxM
paralogues is carried by a plasmid, both enzymes catalyze the transfer of the same fatty
acid to the lipid A, and PhoPQ is a positive regulator (40–42).
The fact that PhoPQ is activated by different signals in vivo and in vitro raises the
intriguing notion that K. pneumoniae may regulate the acylation of its 2= R-3-
hydroxymyristoyl group in response to environmental signals. Furthermore, our data
suggest that the presence of lipid A species m/z 1797 may indicate an environment
where PhoPQ activity is repressed. We have recently reported the detection of lipid A
species m/z 1797 in K. pneumoniae isolates that reached the spleens of intranasally
infected mice (23), hence suggesting that PhoPQ activity may be diminished in the
spleens of infected mice. On the other hand, it is interesting to consider why K.
pneumoniae may prefer LpxL2-mediated acylation versus LpxL1-controlled acylation.
Although there are potentially several explanations, it is worth noting that in K.
pneumoniae LpxO-dependent hydroxylation occurs only in the C14 transferred to the 2=
R-3-hydroxymyristoyl group by LpxL2 (23; this work), and we have demonstrated that
deletion of lpxO attenuates K. pneumoniae virulence in vivo (23, 30). The fact that PhoPQ
is a positive regulator of lpxO (23) further underscores the importance of PhoPQ-
mediated negative regulation of lpxL1.
It was unexpected to observe the lack of 4-amino-4-deoxy-L-arabinose and palmitate
decorations in the lipid A produced by the lpxL2 mutant. Notably, this phenotype was
speciﬁc for lpxL2 inactivation since we did not observe any effect on lipid A decorations
of the lipid A molecules produced by lpxL1 and lpxM mutants (23, 26; this work). This
is in stark contrast to the ﬁndings for E. coli and Salmonella enterica serovar Typhimu-
rium, where lpxM inactivation results in the loss of 4-amino-4-deoxy-L-arabinose (43).
We cannot rule out the possibility that the lack of myristoylation in K. pneumoniae lipid
A impairs the enzymatic activity of PmrK/ArnT and PagP, responsible for transferring
4-amino-4-deoxy-L-arabinose and palmitate to the lipid A, respectively. However, our
data demonstrate that transcription of phoPQ and pmrAB, which encode two-
component systems which govern the expression of pagP and the pmrF (arn) operon,
respectively (24), were downregulated in the lpxL2 mutant with a concomitant down-
regulation of the expressions of pagP and the pmrF (arn) operon. Interestingly, we did
not observe an increase in the level of lpxL1 transcription in the lpxL2 mutant back-
ground (see Fig. S7 in the supplemental material), despite the decrease in the level of
phoPQ expression in this mutant. This result may indicate that the low levels of phoP in
the lpxL2 mutant background are enough to repress lpxL1 expression but are not
sufﬁcient to increase the levels of expression of pagP and the pmrF operon. However,
by no means do we rule out the possibility that there might be other regulatory
systems controlling lpxL1 expression. Future research efforts will be devoted to the
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detailed characterization of lpxL1 expression and to the identiﬁcation of any additional
putative lpxL1 regulator.
Another novel ﬁnding of this work is that the lpxL2 mutant elicited higher inﬂam-
matory responses than the wild type. This observation challenges the conventional
wisdom that Enterobacteriaceae late acyltransferase lipid A mutants elicit limited acti-
vation of inﬂammatory responses (40, 44, 45). Mechanistically, our data are consistent
with the notion that the lpxL2 mutant-induced heightened inﬂammation is due to the
lack of the LpxO-mediated lipid A modiﬁcation. This is in perfect agreement with our
recent work demonstrating that K. pneumoniae LPS containing 2-hydroxymyristate is
less inﬂammatory than that lacking this modiﬁcation (23). Our data also suggest that
the contribution of lpxL2 to polymyxin resistance, phagocytosis evasion, and virulence
in the G. mellonella infection model is dependent on LpxO-mediated hydroxylation of
the LpxL2-transferred myristate. These ﬁndings are consistent with those of previous
studies demonstrating the role of the K. pneumoniae LpxO-mediated lipid A modiﬁca-
tion on AP resistance and phagocytosis evasion by professional phagocytes (macro-
phages and amoebae) (23, 25, 46). Altogether, this evidence sustains the notion that
LpxO-controlled lipid A hydroxylation plays a major role in K. pneumoniae strategies to
counter host defense mechanisms. The generalization that the presence of a hydroxyl
group on a lipid A secondary acyl chain is a bacterial mechanism to evade innate
immune defenses warrants further studies. However, providing additional support to
this notion, hydroxylation on the 3=-linked secondary acyl chain of Vibrio cholerae also
promotes resistance to APs (47). The fact that several other Gram-negative bacterial
pathogens synthesize lipid A species that possess a hydroxyl group on a secondary acyl
chain (Salmonella, Pseudomonas, Legionella, Acinetobacter, Vibrio) (6, 48–50) might
suggest that this lipid A modiﬁcation is a conserved microbial anti-immune mechanism.
Finally, the clinical implications of our ﬁndings are worth discussing. K. pneumoniae
has recently been singled out to be an urgent threat to human health by the World
Health Organization, the U.S. Centers for Disease Control and Prevention, and the UK
Department of Health due to the increasing number of multidrug-resistant isolates. K.
pneumoniae infections are particularly a problem among neonates, elderly individuals,
and immunocompromised individuals within the health care setting, but this organism
is also responsible for a signiﬁcant number of community-acquired infections, including
pneumonia and sepsis (10, 11). The evidence presented in this work warrants further
investigation of the lpxL2 gene product as a novel target for antimicrobial therapy. Even
though compounds targeting LpxL2 might not inhibit the growth of Klebsiella, since the
growth kinetics of lpxL2 and lpxOmutants were not affected, our data suggest that they
will render the bacterium susceptible to APs and will also increase inﬂammatory
responses. Both actions should facilitate the clearance of the pathogen from the
airways, which might be further enhanced with the aid of antibiotics. However, the
clinical utility of any molecule active against lpxL2, when and if such a molecule is
developed, remains to be determined.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains and plasmids used in this study are
listed in Table 1. Strains were grown in lysogeny broth (LB) medium at 37°C on an orbital shaker (180
rpm). When appropriate, the following antibiotics were added to the growth medium at the indicated
concentrations: ampicillin (Amp) at 100 g/ml, kanamycin (Km) at 50 g/ml, chloramphenicol (Cm) at 25
g/ml, and trimethoprim (Tp) at 100 g/ml.
To assess the growth of K. pneumoniae strains, bacteria were grown at 37°C in 5 ml of LB medium
on an orbital shaker (180 rpm) overnight, and 5 l of this culture was added to 250 l of either LB or M9
minimal medium. Absorbance readings at an optical density of 600 nm (OD600) were measured at 20-min
intervals over a 24-h period using a Bioscreen C automated microbial growth analyzer (MTX Lab Systems,
Vienna, VA, USA). A total of 5 independent growth curves were obtained for each strain.
K. pneumoniae mutant construction. Primers for mutant construction (see Table S1 in the supple-
mental material) were designed on the basis of the whole-genome sequence of K. pneumoniae 52.145
(GenBank accession no. FO834906.1). Two sets of primers, Lpxl1UP and LpxL1DOWN, were used to
amplify two lpxL1 fragments by PCR using Ex Taq polymerase (TaKaRa). These fragments were annealed
at their overlapping regions, ampliﬁed as a single fragment, and cloned into the pGEM-T Easy vector
(Promega) to obtain pGEMTlpxL1. A similar approach was followed to obtain pGEMTlpxL2. A kanamycin
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resistance cassette was obtained as a BamHI fragment from pGEMTFRTKm (24) and cloned into
BamHI-digested pGEMTΔlpxL-1 and pGEMTΔlpxL-2 to generate pGEMTΔlpxL1Km and pGEMTΔlpxL2Km,
respectively. The lpxL-1Km and lpxL-2Km fragments (3.5 kb each) were subsequently obtained by NotI
digestion, gel puriﬁed, and cloned into NotI-digested pJTOOL-1. pJTOOL-1 is a suicide vector that carries
an R6K origin of replication, an oriT sequence for conjugational transfer, and a Cm resistance marker (51).
It also carries the sacB gene, which mediates sucrose sensitivity as a positive selection for the excision of
the vector after double crossing-over (51). pJTOOL-1-lpxL1Km and pJTOOL-1-lpxL2Km were transformed
into E. coli 2163, from which the plasmids were mobilized into K. pneumoniae 52.145 by conjugation.
Transconjugants were selected after growth on LB plates supplemented with Cm at 37°C. A total of 10
merodiploids were serially diluted in PBS, spread on LB plates without NaCl containing 6% sucrose, and
incubated at 25°C. The recombinants that survived 6% sucrose were checked for their antibiotic
resistance, and the appropriate replacement of the wild-type alleles by the mutant ones was conﬁrmed
by PCR. The recombinants selected were named 52145ΔlpxL1Km and 52145ΔlpxL2Km. The Km resistance
cassettes were excised by FLP-mediated recombination using plasmid pFLP2 (52), as we have previously
described (24). The mutants selected were named 52145-ΔlpxL1 and 52145-ΔlpxL2, respectively.
The lpxL1 lpxL2 double mutant strain 52145-ΔlpxL1ΔlpxL2 was obtained by mobilizing pJTOOL-1-
lpxL2Km into 52145-ΔlpxL1. The replacement of the wild-type allele by the mutant one was done as
described above and conﬁrmed by PCR.
The lpxL1 phoQ double mutant strain 52145-ΔlpxL1ΔphoQ was obtained by mobilizing
pMAKSACBΔphoQGB (24) into 52145-ΔlpxL1. The lpxO mutant strain 52145-ΔlpxO was constructed by
mobilizing pMAKSACBΔlpxO (25) into K. pneumoniae 52.145. The replacement of the wild-type alleles by
the mutant one was done as described above and conﬁrmed by PCR.
Complementation of K. pneumoniae mutants. To complement the lpxL mutants, DNA fragments
containing the putative promoter region and coding region of lpxL1 and lpxL2 were PCR ampliﬁed using
Ex Taq polymerase, gel puriﬁed, and cloned into pGEM-T Easy to obtain pGEMTlpxL1Com and
pGEMTlpxL2Com, respectively. These plasmids were then electroporated into K. pneumoniae and E.
coli mutant strains, and clones were selected after growth on LB plates supplemented with Amp at
37°C. For single-copy chromosomal complementation, PvuII fragments from pGEMTlpxL1Com and
pGEMTlpxL2Com were gel puriﬁed and cloned into SmaI-digested pUC18R6kT-mini-Tn7-T-Km (53) to
obtain pUC18R6kT-mini-Tn7-T-Km-lpxL1Com and pUC18R6kT-mini-Tn7-T-Km-lpxL2Com, respec-
tively. The pSTNSK-Tp plasmid, which contains the transposase tnsABCD necessary for Tn7 transpo-
sition (54), was electroporated into the K. pneumoniae lpxL mutants. The pUC18R6kT-mini-Tn7-T-Km-
lpxL1 and pUC18R6kT-mini-Tn7-T-Km-lpxL2 plasmids were then mobilized by conjugation into the
mutants harboring pSTNSK-Tp. Colonies were checked for resistance to Km and sensitivity to Amp. As
the Amp resistance cassette is located outside the Tn7 region of the vector, Amp sensitivity denotes the
integration of the Tn7 derivative at the att Tn7 site instead of incorporation of the vector into the
chromosome. Conﬁrmation of integration of the Tn7 transposon at the established att Tn7 site located
downstream of the glmS gene was veriﬁed by PCR, as we have previously described (25, 55). Because the
origin of replication of plasmid pSC101 is thermosensitive, the recipient strains were cured of pSTNSK-Tp
by growing the bacteria at 37°C. Plasmid removal was conﬁrmed by susceptibility to Tp.
E. coli lpxL mutant construction. The bacterial mutant BN1 ΔlpxL was created using the Red
recombinase system (56). Strain BN1 is an lpxT, eptA, and pagP mutant (57). A Km resistance cassette
ﬂanked by FLP recombination target (FRT) sites was PCR ampliﬁed using the pKD46 plasmid as a
template (56). The primers used for ampliﬁcation incorporated homologous extensions to the lpxL gene
(Table S1). The PCR product was gel puriﬁed and treated with DpnI, and 1 g of the DNA was
electroporated into E. coli BN1 harboring the pKD46 plasmid (56). Mutants were selected on LB agar
containing Km, and a recombinant in which the wild-type allele was replaced by the mutant one was
selected. The appropriate replacement of the wild-type allele by the mutant one was conﬁrmed by PCR,
and the Km cassette was subsequently excised by FLP-mediated recombination using plasmid pFLP2.
The strain generated was named BN1 ΔlpxL.
Construction of reporter fusions. DNA fragments containing the promoter regions of the lpxL1 and
lpxL2 genes were ampliﬁed by PCR using Phusion polymerase (NEB), EcoRI digested, gel puriﬁed, and
cloned into the EcoRI-SmaI-digested pGPL01 suicide vector (58). This vector contains a promoterless
ﬁreﬂy luciferase gene (lucFF) and an R6K origin of replication. Plasmids in which lucFF was under the
control of the Klebsiella promoters were identiﬁed by restriction digestion analysis and named pGPLK-
pnProlpxL1 and pGPLKpnProlpxL2, respectively. Reporter plasmids pGPLKpnPmrH and pGPLKpnPagP
have been described previously (24, 25).
Plasmids were conjugated into the different K. pneumoniae strains, and strains in which the suicide
vector was integrated into the genome by homologous recombination were selected. Correct insertion
of the vectors into the chromosome was conﬁrmed by PCR using the relevant lucFF_check and promoter
sequence primers (Table S1).
Luciferase activity. The reporter strains were grown on an orbital shaker (180 rpm) at 37°C until the
exponential phase and harvested (3,000  g, 20 min, 22°C). The bacteria were then washed once with
sterile PBS and the OD600 was adjusted to 1.0. A 100-l aliquot of the bacterial suspension was mixed
with 100 l of luciferase assay reagent (1 mM D-luciferin [Synchem] in 100 mM citrate buffer [pH 5]).
Luminescence was immediately measured with a Glomax 20/20 luminometer (Promega) and expressed
as the number of relative light units (RLU). All measurements were carried out in quintuplicate on at least
three separate occasions.
Capsule puriﬁcation and quantiﬁcation. Bacterial strains were grown overnight at 37°C overnight
in 3 ml LB medium, and viable counts were determined by dilution plating. The bacteria were then
Klebsiella Lipid A Late Acyltransferase Infection and Immunity
September 2017 Volume 85 Issue 9 e00068-17 iai.asm.org 15
 o
n
 August 7, 2018 by University of Queensland Library
http://iai.asm
.org/
D
ow
nloaded from
 
harvested (3,000  g, 20 min, 22°C), and the cell pellet was resuspended in 500 l of sterile water.
Samples were then treated with 1% 3-(N,N-dimethyltetradecylammonio)propanesulfonate (Sigma) in 100
mM citric acid, pH 2.0, at 50°C for 20 min. The bacterial debris was pelleted (3,000 g, 10 min, 22°C), and
250 l of the supernatant was transferred into a clean 15-ml glass tube. The capsule polysaccharide was
ethanol precipitated at 20°C for 20 min and recovered by centrifugation (9,000  g, 10 min, 4°C). The
pellets were dried (5 min, 90°C) and resuspended in 200 l of sterile water. The capsule was quantiﬁed
by determining the concentration of uronic acid in the samples, using a modiﬁed carbazole assay, as
described by Rahn and Whitﬁeld (59). All extractions and quantiﬁcations were carried out on three
independent occasions.
Isolation and analysis of lipid A. Lipid A molecules were extracted using an ammonium hydroxide-
isobutyric acid method (60) and subjected to negative-ion matrix-assisted laser desorption ionization
(MALDI)–time of ﬂight (TOF) mass spectrometry analysis. Brieﬂy, the bacteria were grown in 10 ml of LB
medium until the exponential phase and washed once with PBS, and the pellet was resuspended in 400
l of isobutyric acid–1 M ammonium hydroxide (5:3 [vol/vol]) in a screw-cap test tube. A sample was then
incubated at 100°C for 2 h with occasional vortexing before being cooled in ice water and centrifuged
(2,000  g for 15 min). The supernatant was transferred to a new tube, diluted with an equal volume of
water, and lyophilized. The lyophilized material was washed twice with 400 l of methanol and
centrifuged (2,000  g for 15 min). The insoluble lipid A was solubilized in 50 to 100 l of chloroform-
methanol-water (3:1.5:0.25 [vol/vol/vol]). To analyze the samples, a few microliters of the lipid A
suspension (1 mg/ml) was desalted with a few grains of ion-exchange resin (H; Dowex 50W-X8) in a
1.5-ml microcentrifuge tube. A 1-l aliquot of the suspension (50 to 100 l) was deposited on the target
and covered with the same amount of dihydroxybenzoic acid matrix (Bruker Daltonics Inc.) dissolved in
acetonitrile–0.1% triﬂuoroacetic acid (1:2 [vol/vol]). Different ratios between the samples and dihydroxy-
benzoic acid were used when necessary. Analyses were performed on a Bruker Autoﬂex speed TOF/TOF
mass spectrometer (Bruker Daltonics Inc.) in negative reﬂective mode with delayed extraction. The
ion-accelerating voltage was set at 20 kV. Each spectrum was an average of 300 shots. A peptide
calibration standard (Bruker Daltonics Inc.) was used to calibrate the MALDI-TOF/TOF mass spectrometer.
Further calibration for lipid A analysis was performed externally using lipid A extracted from E. coli strain
MG1655 grown in LB medium at 37°C. Interpretation of the negative-ion spectra was based on earlier
studies showing that ions with masses higher than 1,000 give signals proportional to the signals of the
corresponding lipid A species present in the preparation (23, 24, 61). Important theoretical masses for the
interpretation of peaks found in the present study are as follows: C14:OH, 226; C12, 182; C14, 210;
4-amino-4-deoxy-L-arabinose, 131; and C16, 239. The spectra are representative of those from at least
three independent lipid A extractions.
Infection of Galleria mellonella larvae. G. mellonella larvae were acquired from UK Waxworms Ltd.
and kept at 21°C in the dark. The larvae were used within 3 days of receipt. Larvae of approximately 250
to 350 mg were selected for the experiments.
Infections were performed as we have described previously with minor modiﬁcations (30). Brieﬂy,
bacteria were grown in 5 ml LB medium until exponential phase and harvested (3,000 g, 20 min, 22°C).
The bacteria were subsequently washed once with 10 mM PBS (pH 6.5) and diluted in PBS to an OD600
of 1.0, which corresponds to approximately 5 108 CFU/ml. After surface disinfection using ethanol (70%
[vol/vol]), the larvae were injected in the last right proleg with 10 l of the bacterial suspension
containing approximately 1  105 CFU using a Hamilton syringe with a 30-gauge needle. A group of 10
larvae was injected with 10 l of PBS in parallel to ensure that death was not due to trauma from the
injection. The larvae were placed in 9.2-cm petri dishes and kept at 37°C in the dark. Insects were
considered dead when they did not respond to physical stimuli. The larvae were examined for pigmen-
tation, and the time of death was recorded. Assays were allowed to proceed for only 3 days, as pupa
formation could occasionally be seen by day 4. At least three independent experiments (30 larvae per
strain) were performed.
RNA isolation and RT-qPCR. Bacteria were grown in 5 ml LB medium until they reached an OD600
of 1.0. An equal volume of RNAlater stabilization solution (Ambion) was added to the culture, and the
culture was incubated at room temperature (22°C) for 30 min. The bacteria were then centrifuged
(3,000  g, 20 min, 22°C), and the supernatant was removed. Total RNA was extracted from the bacterial
pellets using the TRIzol reagent (Ambion). Extracted RNA was treated with DNase I (Roche) and
precipitated with sodium acetate (Ambion) and ethanol. RNA was quantiﬁed using a Nanovue Plus
spectrophotometer (GE Healthcare Life Sciences).
cDNA was obtained by retrotranscription of 1 g of total RNA using commercial Moloney murine
leukemia virus reverse transcriptase (Invitrogen) and random primers (Invitrogen). Twenty nanograms of
cDNA was used as a template in 20 l of the reaction mixture from a KapaSYBR Fast qPCR kit (Kapa
Biosystems) and primer mix. RT-qPCR analyses were performed using an Mx3005P instrument (Agilent)
and the following thermocycling protocol: 95°C for 3 min for hot-start polymerase activation, followed
by 40 cycles of 95°C for 10 s and 56°C for 30 s. The ﬂuorescence of the SYBR green dye was measured
at 521 nm. Relative quantities of mRNAs were obtained using the comparative threshold cycle (ΔΔCT)
method by normalization to the amount of rpoD. cDNAs were obtained from three independent
extractions of RNA, and each cDNA was ampliﬁed by RT-qPCR.
Antimicrobial peptide susceptibility assays. Bacteria were grown at 37°C in 5 ml of LB medium and
harvested (3,000  g, 20 min, 22°C) when they were in the exponential growth phase. The bacteria were
then washed once with PBS, and a suspension containing 4  104 CFU/ml was prepared in 10 mM PBS
(pH 6.5), 1% tryptone soy broth (Oxoid), and 100 mM NaCl. Aliquots of the suspension (25 l) were mixed
in 0.2-ml tubes with the appropriate antibiotic at a ﬁnal concentration of 3 g/ml to give a ﬁnal volume
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of 30 l. After 1 h of incubation at 37°C, 15 l was plated on LB agar and colony counts were determined
after incubation at 37°C for 24 h. The results were expressed as a percentage of the colony count of
bacteria not exposed to antibiotics. All experiments were performed with duplicate samples on three
independent occasions.
MICs were determined by Etest (bioMérieux) according to the manufacturer’s instructions. MIC
testing was performed on two independent occasions.
Whole-blood phagocytosis assay. Bacteria were grown at 37°C in 5 ml of LB medium on an orbital
shaker (180 rpm) until the exponential phase and harvested (3,000  g, 20 min, 22°C). The bacteria were
subsequently washed once and diluted in PBS to an OD600 of 1.0. Further dilutions in PBS were made to
obtain 1  107 CFU/100 l bacterial suspensions. Three hundred microliters of fresh human blood (used
within 30 min of removal) was mixed with 1  107 CFU/100 l bacterial suspension and incubated at
37°C on an orbital shaker (180 rpm) for 3 h. After incubation, dilutions were plated to obtain viable
counts. The bacterial counts recovered were then divided by the initial counts. Experiments were
performed using blood from three individual blood donors, and for each blood sample, each strain was
tested in duplicate. Ethical approval for the use of blood from healthy volunteers to study bacterial killing
was from the Research Ethics Committee of the School of Medicine, Dentistry, and Biomedical Sciences
(Queen’s University Belfast).
Macrophage infections. Immortalized murine bone marrow-derived macrophages (iBMDMs; the
macrophage cell line was derived from wild-type NR-9456 mice; BEI Resources, NIAID, NIH) were grown
in Dulbecco’s modiﬁed Eagle medium (DMEM; catalog number 41965; Gibco) supplemented with 10%
heat-inactivated fetal calf serum (FCS), 100 U/ml penicillin, and 0.1 mg/ml streptomycin (Gibco) at 37°C
in a humidiﬁed 5% CO2 incubator. Cells were routinely tested for Mycoplasma contamination. For
infections, iBMDMs were seeded at 2.5  105 cells per well in 96-well plates.
To prepare the inocula for infections, bacteria were grown until exponential phase in 5 ml LB
medium, supplemented with the appropriate antibiotics, when required, at 37°C on an orbital shaker
(180 rpm). Bacteria were recovered by centrifugation (3,000  g, 20 min, 22°C), washed once with PBS,
and diluted in PBS to an OD600 of 1.0, which corresponds to approximately 5 108 CFU/ml. This bacterial
suspension was UV irradiated at 1 J for 20 min, and bacterial killing was conﬁrmed by plating in LB
medium. Bacterial suspensions were stored at80°C. iBMDMs were challenged with 1 105 bacteria for
6 h, and supernatants were collected for cytokine determination. Experiments were performed in
duplicate and repeated three independent times.
Cytokine quantiﬁcation. Cytokines in the supernatants were determined using Luminex multiplex
assays (R&D Systems, Abingdon, UK) as recommended by the manufacturer. Analyses were performed
using a Bio-Plex 100 system with the xMAP technology (Bio-Rad, Hertfordshire, UK).
Statistical analysis. Statistical analyses were performed using one-way analysis of variance (ANOVA)
with Bonferroni contrasts, the one-tailed t test, or, when the requirements were not met, the Mann-
Whitney U test. A P value of 0.05 was considered statistically signiﬁcant. Survival analyses were
undertaken using the log-rank (Mantel-Cox) test with the Bonferroni correction for multiple comparisons
( 	 0.008). The analyses were performed using Prism (version 4) software for the personal computer
(GraphPad Software).
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